Tirzepatide has been studied in two massive clinical trial programs, SURPASS for type 2 diabetes and SURMOUNT for weight management, collectively enrolling tens of thousands of participants across multiple countries and treatment durations
10.1371/journal.pone.0106338 78 InoueS.KawashimaM.HisamuraR.ImadaT.IzutaY.NakamuraS.et al (2017)
doi: 10.1016/j.obpill.2025.100220
Poblaciones especiales: No es necesario ningn ajuste de dosis de semaglutida basado en la edad, gnero, raza, origen tnico, peso corporal, deterioro renal o heptico
This may result in difficulty closing the eyes fully or weakness in the facial muscles
Chinas Hangzhou Jiuyuan Gene Engineering, owned by pharmaceutical behemoth Huadong Medicine, earlier this year applied for approval to sell the first homegrown rival to Ozempic